Jodhpur, July 12, 2025: Medanta, one of India's leading super-specialty hospitals, ranked as the Best Private Hospital in India by Newsweek for six consecutive years, held OPD services in Jodhpur, Rajasthan, focusing on the advanced treatment of two common blood disorders: thalassemia and aplastic anaemia. 

The OPD was led by Dr. Satya Prakash Yadav, Senior Director, Paediatric Hemato Oncology and Bone Marrow Transplant, Medanta, Gurugram. The objective of this OPD was to provide advanced, specialized care for patients suffering from thalassemia and aplastic anaemia, including expert consultation for bone marrow transplant (BMT) cases. This initiative aimed to bring world-class treatment and expert consultation closer to patients in the region. Subsequently, Dr. Yadav also spearheaded an awareness session targeted at medical professionals regarding the early diagnosis and advanced treatment for thalassemia and aplastic anemia. Additionally, as part of the awareness initiative, Medanta on July 13, 2025 organized a patient’s camp offering free check-ups and HLA typing – a crucial test to find matching bone marrow donors. 

Both thalassemia and aplastic anemia are serious pediatric blood disorders with significant health consequences. Thalassemia, a genetic disorder, requires lifelong blood transfusions. Aplastic anemia, a rarer but equally serious condition, causes bone marrow failure. India faces a substantial burden of both, with 10,000-15,000 children born with thalassemia major annually, and Rajasthan showing high prevalence[1]. Approximately 20,000 new aplastic anemia cases are diagnosed yearly nationwide, with it being the second most common cause of pancytopenia in Rajasthan[2],[3]. Limited awareness, delayed diagnosis, and restricted access to treatments like Bone Marrow Transplant (BMT) remain major challenges for many families. However, advancements like BMT and gene therapies offer curative hope, potentially reducing lifelong transfusions for thalassemia and providing options for aplastic anemia.

Dr. Satya Prakash Yadav, Senior Director, Paediatric Hemato Oncology and Bone Marrow Transplant, Medanta, Gurugram, emphasized the importance of awareness and access. He said, “Blood disorders like thalassemia and aplastic anemia are not just medical challenges but also emotional and financial burdens on families. Bone Marrow Transplant offers a life-changing cure, but many children remain undiagnosed or untreated due to a lack of awareness and resources. At Medanta, through this specialized OPD and outreach, we aim to provide accessible, world-class care and ensure every child has the chance to lead a healthy life.”

Dr. Yadav further emphasized the need for doctors, healthcare providers, policymakers, and the public to work together in raising awareness, dispelling myths, and creating a supportive environment for bone marrow transplants. Through these collective efforts, we can save countless lives and significantly improve the health outcomes for thousands of children affected by thalassemia and aplastic anemia.   

These services in Jodhpur are a part of Medanta’s broader commitment, including its collaboration with Coal India under the ‘Thalassemia Bal Sewa Yojana,’ which provides financial assistance of up to ₹10 lakh for BMT procedures for underprivileged children.

[1] Chavan, V. (2024, March 27). Tackling Thalassemia: Transformation through Collaboration. ETHealthworld.com. https://health.economictimes.indiatimes.com/news/industry/tackling-thalassemia-transformation-throughcollaboration/108797490#:~:text=India%20has%20the%20highest%20count,thalassemia%20major%20in%20the%20country
[2] 2 Chavan, V. (2024, March 27). Tackling Thalassemia: Transformation through Collaboration. ETHealthworld.com. https://health.economictimes.indiatimes.com/news/industry/tackling-thalassemia-transformation-throughcollaboration/108797490#:~:text=India%20has%20the%20highest%20count,thalassemia%20major%20in%20the%20country
[3] http://impactfactor.org/PDF/IJPCR/17/IJPCR,Vol17,Issue1,Article134.pdf